Douglas Boothe
CIK 1566118 · President and CEO · last filed 2026-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.8K
Companies
3
Total Filings
16
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKORN INC (AKRX) Delisted | President and CEO | 466,261 | — | — | $0 | 2 | 2020-01-10 |
| Impax Laboratories, LLC (IPXL) Delisted | President, Generics Division | 78,549 | — | — | $0 | 4 | 2018-03-05 |
| PRGO | EVP & GM Perrigo Pharma | 803 | $10.99 | $8.8K | $0 | 8 | 2016-03-01 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-01 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2014-08-25 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2013-12-20 | PRGO | Grant (A) | +1 | $0 | EDGAR |
| 2013-12-19 | PRGO | Disp (D) | −1 | $0 | EDGAR |
| 2013-08-26 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2013-01-16 | PRGO | Grant (A) | — | $0 | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.